Avanos Medical (AVNS) Short-Term Debt repayments (2016 - 2025)

Avanos Medical's Short-Term Debt repayments history runs 7 years deep, the most recent figure standing at $25.0 million for Q1 2025.

• In Q1 2025, Short-Term Debt repayments rose 150.0% year-over-year to $25.0 million; the TTM figure through Dec 2025 stood at $25.0 million (down 44.44% YoY), while the FY2025 annual figure was $25.0 million, down 44.44% from the prior year.
• Short-Term Debt repayments came in at $25.0 million for Q1 2025 at Avanos Medical, roughly flat from $25.0 million in the prior quarter.
• In the past five years, Short-Term Debt repayments ranged from a high of $130.0 million in Q2 2022 to a low of -$55.0 million in Q4 2021.
• A 5-year average of $27.3 million and a median of $20.0 million in 2022 frame the typical range for Short-Term Debt repayments.
• Across the five-year window, Short-Term Debt repayments sank 1200.0% in 2021 and jumped 1200.0% in 2022, its largest moves.
• Avanos Medical's Short-Term Debt repayments stood at -$55.0 million in 2021, then jumped by 136.36% to $20.0 million in 2022, then jumped by 375.0% to $95.0 million in 2023, then slumped by 73.68% to $25.0 million in 2024, then changed by 0.0% to $25.0 million in 2025.
• According to Business Quant data, Short-Term Debt repayments over the past three periods registered $25.0 million, $25.0 million, and $10.0 million for Q1 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison